• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Medivation - Articles and news items

Medivation’s Board

Medivation in confidentiality agreements with Sanofi and others

Industry news / 6 July 2016 / Victoria White, Digital Content Producer

Medivation has entered into confidentiality agreements with parties that have expressed interest in exploring a potential transaction to acquire the company…

Pidilizumab shows potential clinical benefit in children with DIPG

Industry news / 16 June 2016 / Victoria White, Digital Content Producer

Results from a Phase I/II study of pidilizumab demonstrated potential clinical benefit in paediatric patients with diffuse intrinsic pontine glioma (DIPG)…

Medivation’s Board

Sanofi files consent solicitation to replace Medivation’s Board

Industry news / 25 May 2016 / Victoria White, Digital Content Producer

Sanofi says it had ‘no choice’ but to commence a process to elect eight independent directors who are more open to evaluating Sanofi’s takeover proposal…

Medivation’s Board

Medivation’s Board rejects Sanofi’s unsolicited proposal

Industry news / 3 May 2016 / Victoria White, Digital Content Producer

Medivation’s Board has determined that the proposal from Sanofi to acquire Medivation for $52.50 per share substantially undervalues the company…

Medivation’s Board

Sanofi makes $9.3b offer to acquire Medivation

Industry news / 28 April 2016 / Victoria White, Digital Content Producer

Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi…

Phase III enzalutamide trial initiated in mHSPC

Industry news / 29 March 2016 / Victoria White

The ARCHES trial will evaluate the efficacy and safety of enzalutamide with androgen deprivation therapy (ADT) versus placebo with ADT in mHSPC patients…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +